THOMPSON SIEGEL & WALMSLEY LLC - FURIEX PHARMACEUTICALS INC ownership

FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 114 filers reported holding FURIEX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of FURIEX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$31,709,000
+25.7%
364,463
-39.3%
0.71%
+21.0%
Q4 2013$25,232,000
+4.0%
600,615
+8.9%
0.59%
+12.0%
Q3 2013$24,265,000
+90.1%
551,606
+47.3%
0.53%
+90.9%
Q2 2013$12,761,000374,5770.28%
Other shareholders
FURIEX PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Magnetar Financial LLC 950,000$100,871,0001.68%
Camber Capital Management LP 200,000$21,236,0001.39%
OXFORD ASSET MANAGEMENT LLP 378,901$40,080,0001.30%
Magnetar Financial LLC 734,006$77,937,0001.30%
HARVEST MANAGEMENT LLC 10,077$1,070,0001.08%
FRANKLIN STREET ADVISORS INC /NC 48,755$5,177,0000.99%
ARROWGRASS CAPITAL PARTNERS (US) LP 251,319$26,685,0000.78%
Biondo Investment Advisors, LLC 19,385$2,058,0000.65%
Andromeda Capital LLC 75,100$7,974,0000.56%
CSS LLC/IL 126,200$13,399,0000.56%
View complete list of FURIEX PHARMACEUTICALS INC shareholders